Formed by the merger of Gyros AB, founded in 2000, and Protein Technologies Inc., founded in 1985. Gyros Protein Technologies AB helps scientists in academia and industry to increase biomolecule performance and productivity in research, drug discovery, pre-clinical and clinical development, and bioprocess applications. As a leading provider of solutions for peptide synthesis and bioanalysis, Gyros Protein Technologies delivers solutions that accelerate the discovery, development and manufacture of safer biotherapeutics.

The Gyrolab platform uses groundbreaking technology to automate immunoassays at nanoliter scale, so you can reach your laboratory goals faster and deliver results that make a difference.

Using an affinity flow-through format, highly reproducible nanoliter microfluidics, and parallel processing, the Gyros platform simplifies assay workflows and shortens run times while delivering high-quality immunoassay data.

Whether you are looking for a complete system, a kit, or components, our platforms miniaturize, integrate, and automate your sample analysis at scale, maximizing your productivity and helping your lab make data-driven decisions – fast.